| COVID-19 |
1 |
0.96 |
| Estrogen |
0 |
0.92 |
| Breast Cancer |
0 |
0.84 |
| Cancer |
0 |
0.24 |
| Breast |
0 |
0.19 |
| Hormonal Therapy |
0 |
0.14 |
| Hormone Replacement Therapy |
0 |
0.95 |
| Clinical Research |
0 |
0.1 |
| Pandemic |
0 |
0.1 |
| Salary and Compensation |
0 |
0.1 |
| Menopause |
0 |
0.09 |
| Obesity |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Exercise |
0 |
0.05 |
| Microbiology |
0 |
0.05 |
| Pharmacoepidemiology |
0 |
0.05 |
| Residency |
0 |
0.05 |
| Severe Acute Respiratory Syndrome |
0 |
0.05 |
| Acute Respiratory Distress Syndrome |
0 |
0.03 |
| Microbiome |
0 |
0.03 |